This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tai, A. L.S. Articles by Guan, X.-Y. Search for Related Content PubMed PubMed Citation Articles by Tai, A. L.S. Articles by Guan, X.-Y.

High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism Markers

Departments of ¹ Clinical Oncology, ² Biochemistry, and ³ Psychiatry, ⁴ Genome Research Center, The University of Hong Kong, Hong Kong, China and ⁵ State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-Sen University, Guangzhou, China

Requests for reprints: Xin-Yuan Guan, Department of Clinical Oncology, The University of Hong Kong Medical Center, Room 109, Estate Building, 10 Sassoon Road, Pokfulam, Hong Kong, China. Phone: 852-25890458; Fax: 852-28169126; E-mail: xyguan{at}hkucc.hku.hk.

Loss of DNA copy number at the short arm of chromosome 3 is one of the most common genetic changes in human lung cancer, suggesting the existence of one or more tumor suppressor genes (TSG) at 3p. To identify most frequently deleted regions and candidate TSGs within these regions, a recently developed single-nucleotide polymorphism (SNP)-mass spectrometry-genotyping (SMSG) technology was applied to investigate the loss of heterozygosity (LOH) in 30 primary non–small-cell lung cancers. A total of 386 SNP markers that spanned a region of 70 Mb at 3p, from 3pter to 3p14.1, were selected for LOH analysis. The average intermarker distance in the present study is 180 kb. Several frequently deleted regions, including 3p26.3, 3p25.3, 3p24.1, 3p23, and 3p21.1, were found. Several candidate TSGs within these frequently detected LOH regions have been found, including APG7L at 3p25.3, CLASP2 at 3p23, and CACNA2D3 at 3p21.1. This study also showed that SMSG technology is a very useful approach to rapidly define the minimal deleted region and to identify target TSGs in a given cancer. (Cancer Res 2006; 66(8): 4133-8)

This article has been cited by other articles:

				M. D. Onken, L. A. Worley, and J. W. Harbour A Metastasis Modifier Locus on Human Chromosome 8p in Uveal Melanoma Identified by Integrative Genomic Analysis Clin. Cancer Res., June 15, 2008; 14(12): 3737 - 3745. [Abstract] [Full Text] [PDF]

				G. E. Carpagnano, M. P. Foschino-Barbaro, A. Spanevello, O. Resta, F. Carpagnano, G. Mule, R. Pinto, S. Tommasi, and A. Paradiso 3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 337 - 341. [Abstract] [Full Text] [PDF]

				D. Angeloni Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease Brief Funct Genomic Proteomic, May 24, 2007; (2007) elm007v1. [Abstract] [Full Text] [PDF]

				M. D. Onken, L. A. Worley, E. Person, D. H. Char, A. M. Bowcock, and J. W. Harbour Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma Clin. Cancer Res., May 15, 2007; 13(10): 2923 - 2927. [Abstract] [Full Text] [PDF]